1. Congenital Heart Disease – Pipeline Review, H1
2012
Aarkstore.com announces, The Latest market research report is available in
its vast collection:
RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml
Summary
Global Markets Direct’s, Congenital Heart Disease - Pipeline Review, H1 2012,
provides an overview of the Congenital Heart Disease therapeutic pipeline. This
report provides information on the therapeutic development for Congenital Heart
Disease, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Congenital Heart Disease. Congenital Heart Disease - Pipeline
Review, H1 2012 is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Congenital Heart Disease.
- A review of the Congenital Heart Disease products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
2. Congenital Heart Disease – Pipeline Review, H1
2012
therapeutics.
Table of contents:
2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Congenital Heart Disease Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Congenital Heart Disease 8
Congenital Heart Disease Therapeutics under Development by Companies 10
Congenital Heart Disease Therapeutics under Investigation by
Universities/Institutes 11
Late Stage Products 13
Comparative Analysis 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Early Clinical Stage Products 15
Comparative Analysis 15
Pre-Clinical Stage Products 16
Comparative Analysis 16
Congenital Heart Disease Therapeutics – Products under Development by
Companies 17
Congenital Heart Disease Therapeutics – Products under Investigation by
Universities/Institutes 18
Companies Involved in Congenital Heart Disease Therapeutics Development 19
Palatin Technologies, Inc. 19
Cardioxyl Pharmaceuticals, Inc. 20
PLx Pharma Inc. 21
Asklepion Pharmaceuticals, LLC. 22
Congenital Heart Disease – Therapeutics Assessment 23
Assessment by Monotherapy Products 23
Assessment by Route of Administration 24
Assessment by Molecule Type 26
3. Congenital Heart Disease – Pipeline Review, H1
2012
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
Gastritis – Pipeline Review, H1 2012
Amnesia – Pipeline Review, H1 2012
Primary Biliary Cirrhosis – Pipeline Review, H1 2012
Congenital Heart Disease – Pipeline Review, H1 2012
Emphysema – Pipeline Review, H1 2012
Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H1 2012
Pheochromocytoma – Pipeline Review, H1 2012
Neuralgia – Pipeline Review, H1 2012
Thromboembolism – Pipeline Review, H1 2012
Obsessive-Compulsive Disorder – Pipeline Review, H1 2012
4. Congenital Heart Disease – Pipeline Review, H1
2012
Bone Cancer – Pipeline Review, H1 2012
Status Epilepticus – Pipeline Review, H1 2012
Thrombocythaemia Myelofibrosis – Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com